15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      MT-CYB mutations in hypertrophic cardiomyopathy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mitochondrial dysfunction is a characteristic of heart failure. Mutations in mitochondrial DNA, particularly in MT-CYB coding for cytochrome B in complex III (CIII), have been associated with isolated hypertrophic cardiomyopathy (HCM). We hypothesized that MT-CYB mutations might play an important causal or modifying role in HCM. The MT-CYB gene was sequenced from DNA isolated from blood from 91 Danish HCM probands. Nonsynonymous variants were analyzed by bioinformatics, molecular modeling and simulation. Two germline-inherited, putative disease-causing, nonsynonymous variants: m.15024G>A; p.C93Y and m.15482T>C; p.S246P were identified. Modeling showed that the p.C93Y mutation leads to disruption of the tertiary structure of Cytb by helix displacement, interfering with protein–heme interaction. The p.S246P mutation induces a diproline structure, which alters local secondary structure and induces a kink in the protein backbone, interfering with macromolecular interactions. These molecular effects are compatible with a leaky phenotype, that is, limited but progressive mitochondrial dysfunction. In conclusion, we find that rare, putative leaky mtDNA variants in MT-CYB can be identified in a cohort of HCM patients. We propose that further patients with HCM should be examined for mutations in MT-CYB in order to clarify the role of these variants.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Knowledge-based protein secondary structure assignment.

          We have developed an automatic algorithm STRIDE for protein secondary structure assignment from atomic coordinates based on the combined use of hydrogen bond energy and statistically derived backbone torsional angle information. Parameters of the pattern recognition procedure were optimized using designations provided by the crystallographers as a standard-of-truth. Comparison to the currently most widely used technique DSSP by Kabsch and Sander (Biopolymers 22:2577-2637, 1983) shows that STRIDE and DSSP assign secondary structural states in 58 and 31% of 226 protein chains in our data sample, respectively, in greater agreement with the specific residue-by-residue definitions provided by the discoverers of the structures while in 11% of the chains, the assignments are the same. STRIDE delineates every 11th helix and every 32nd strand more in accord with published assignments.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mitochondrial threshold effects.

            The study of mitochondrial diseases has revealed dramatic variability in the phenotypic presentation of mitochondrial genetic defects. To attempt to understand this variability, different authors have studied energy metabolism in transmitochondrial cell lines carrying different proportions of various pathogenic mutations in their mitochondrial DNA. The same kinds of experiments have been performed on isolated mitochondria and on tissue biopsies taken from patients with mitochondrial diseases. The results have shown that, in most cases, phenotypic manifestation of the genetic defect occurs only when a threshold level is exceeded, and this phenomenon has been named the 'phenotypic threshold effect'. Subsequently, several authors showed that it was possible to inhibit considerably the activity of a respiratory chain complex, up to a critical value, without affecting the rate of mitochondrial respiration or ATP synthesis. This phenomenon was called the 'biochemical threshold effect'. More recently, quantitative analysis of the effects of various mutations in mitochondrial DNA on the rate of mitochondrial protein synthesis has revealed the existence of a 'translational threshold effect'. In this review these different mitochondrial threshold effects are discussed, along with their molecular bases and the roles that they play in the presentation of mitochondrial diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mitochondrial DNA mutations and human disease.

              Mitochondrial disorders are a group of clinically heterogeneous diseases, commonly defined by a lack of cellular energy due to oxidative phosphorylation (OXPHOS) defects. Since the identification of the first human pathological mitochondrial DNA (mtDNA) mutations in 1988, significant efforts have been spent in cataloguing the vast array of causative genetic defects of these disorders. Currently, more than 250 pathogenic mtDNA mutations have been identified. An ever-increasing number of nuclear DNA mutations are also being reported as the majority of proteins involved in mitochondrial metabolism and maintenance are nuclear-encoded. Understanding the phenotypic diversity and elucidating the molecular mechanisms at the basis of these diseases has however proved challenging. Progress has been hampered by the peculiar features of mitochondrial genetics, an inability to manipulate the mitochondrial genome, and difficulties in obtaining suitable models of disease. In this review, we will first outline the unique features of mitochondrial genetics before detailing the diseases and their genetic causes, focusing specifically on primary mtDNA genetic defects. The functional consequences of mtDNA mutations that have been characterised to date will also be discussed, along with current and potential future diagnostic and therapeutic advances. 2009 Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Mol Genet Genomic Med
                Mol Genet Genomic Med
                mgg3
                Molecular Genetics & Genomic Medicine
                Blackwell Publishing Ltd
                2324-9269
                2324-9269
                May 2013
                12 April 2013
                : 1
                : 1
                : 54-65
                Affiliations
                [1 ]Department of Clinical Biochemistry, Immunology, and Genetics, Statens Serum Institut Copenhagen, Denmark
                [2 ]Department of Biomedical Sciences, University of Copenhagen Copenhagen, Denmark
                [3 ]Institute of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen Copenhagen, Denmark
                [4 ]Department of Cardiology, Roskilde Sygehus Roskilde, Denmark
                [5 ]Department of Biomedical Sciences, Stellenbosch University Cape Town, South Africa
                [6 ]Department of Medicine B, The Heart Center, Rigshospitalet Copenhagen, Denmark
                Author notes
                Michael Christiansen, Department of Clinical Biochemistry, Immunology, and Genetics, Statens Serum Institut, 5 Artillerivej DK 2300 S, Copenhagen, Denmark. Tel: +4532683657; Fax: +4532683860; E-mail: mic@ 123456ssi.dk
                [a]

                C. M. Hagen and F. H. Aidt contributed equally to this work.

                Article
                10.1002/mgg3.5
                3893158
                24498601
                5c1fdaa8-f25e-4328-824c-d93c45c8d372
                © 2013 Wiley Periodicals, Inc.

                Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.

                History
                : 24 January 2013
                : 18 February 2013
                : 21 February 2013
                Categories
                Original Articles

                cardiomyopathy,dna sequencing,genetic disorders,hypertrophy,mitochondria

                Comments

                Comment on this article